Back to News
Market Impact: 0.25

TSLA Quantitative Stock Analysis

TSLANDAQ
Company FundamentalsAnalyst InsightsAutomotive & EV
TSLA Quantitative Stock Analysis

Validea's guru fundamental report rated Tesla (TSLA) at 68% using its Motley Fool-based Small-Cap Growth Investor model, falling below the 80% threshold for 'some interest.' While the large-cap growth stock passed several fundamental tests including profit margin and cash flow, it failed key growth and valuation metrics such as relative strength, sales and EPS growth comparisons, and 'The Fool Ratio,' indicating a mixed fundamental picture despite some underlying strengths.

Analysis

Tesla (TSLA) receives a subdued rating of 68% from Validea's Small-Cap Growth Investor model, a score that falls short of the 80% threshold indicating strategic interest. This assessment, based on the Motley Fool's methodology, presents a dichotomous view of the large-cap automaker. On one hand, TSLA demonstrates notable fundamental strengths, passing criteria for profit margin, profit margin consistency, cash flow from operations, and several balance sheet health metrics including its debt-to-equity ratio and insider holdings. On the other hand, the company fails on several critical growth and performance indicators. Specifically, it fails on relative strength, year-over-year sales and EPS growth comparisons, and "The Fool Ratio" (P/E to Growth), suggesting the stock is lagging in price momentum and appears overvalued relative to its growth. The neutral-to-negative sentiment score of -0.2 aligns with this mixed report, where solid operational fundamentals are overshadowed by concerns around growth deceleration and valuation from the perspective of this specific investment framework.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

Neutral

Sentiment Score

-0.20

Ticker Sentiment

NDAQ0.00
TSLA-0.20

Key Decisions for Investors

  • Investors should scrutinize whether their thesis is based on growth momentum or fundamental quality, as this report highlights strong operational health but weakening performance on key growth and relative strength metrics.
  • A re-evaluation of the stock's valuation is warranted, given its failure on the P/E to Growth ratio metric, which suggests the current price may be too high relative to the growth outlook identified by this specific model.
  • Given the identified weaknesses in year-over-year sales and EPS growth, investors should closely monitor the company's next earnings release for any signs of re-acceleration or further deceleration.